BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24016317)

  • 1. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
    Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
    Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
    Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.
    Weisman O; Guri Y; Gur RE; McDonald-McGinn DM; Calkins ME; Tang SX; Emanuel B; Zackai EH; Eliez S; Schneider M; Schaer M; Kates WR; Antshel KM; Fremont W; Shashi V; Hooper SR; Armando M; Vicari S; Pontillo M; Kushan L; Jalbrzikowski M; Bearden CE; Cubells JF; Ousley OY; Walker EF; Simon TJ; Stoddard J; Niendam TA; van den Bree MBM; Gothelf D;
    Schizophr Bull; 2017 Sep; 43(5):1079-1089. PubMed ID: 28204757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
    Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
    Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
    Niarchou M; Chawner SJRA; Fiksinski A; Vorstman JAS; Maeder J; Schneider M; Eliez S; Armando M; Pontillo M; Vicari S; McDonald-McGinn DM; Emanuel BS; Zackai EH; Bearden CE; Shashi V; Hooper SR; Owen MJ; Gur RE; Wray NR; van den Bree MBM; Thapar A;
    Schizophr Res; 2019 Feb; 204():320-325. PubMed ID: 30093352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome.
    Jolin EM; Weller RA; Weller EB
    J Affect Disord; 2012 Feb; 136(3):222-8. PubMed ID: 21215459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
    Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
    Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
    Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S
    Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.
    Tang SX; Yi JJ; Moore TM; Calkins ME; Kohler CG; Whinna DA; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Bilker WB; Gur RC; Gur RE
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):991-1000.e2. PubMed ID: 25151422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Armando M; Lin A; Pontillo M; Vicari S
    Psychiatry Res; 2017 Aug; 254():238-243. PubMed ID: 28477546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
    Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome.
    Jolin EM; Weller RA; Jessani NR; Zackai EH; McDonald-McGinn DM; Weller EB
    J Affect Disord; 2009 Dec; 119(1-3):177-80. PubMed ID: 19269692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
    Antshel KM; Fremont W; Ramanathan S; Kates WR
    Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.
    Goldenberg PC; Calkins ME; Richard J; McDonald-McGinn D; Zackai E; Mitra N; Emanuel B; Devoto M; Borgmann-Winter K; Kohler C; Conroy CG; Gur RC; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):87-93. PubMed ID: 22170773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions.
    Shashi V; Veerapandiyan A; Schoch K; Kwapil T; Keshavan M; Ip E; Hooper S
    J Intellect Disabil Res; 2012 Sep; 56(9):865-78. PubMed ID: 21883601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.